Feb. 22 at 3:21 AM
$SBFM So why would Dr. Steve approve a “potential” RS ( up to 1 for 10) with the stock trading at all time lows and very low volume?Does the company have any compliance issues? Is the float bloated? Nope, then why?In my opinion the approved RS aligns with buyout speculation, just like the resignation of the COO with no replacement, the approved employee incentive shares (683k), the quietly published patent, and the nearly 4 months of silence. The RS could be requested by a potential buyer especially if it’s a big pharma big dog, to enhance the optics of the deal. A 150M deal for a company trading at
$1.15-1.25 looks much better to the market at
$11-
$13. If the buyout price is already agreed upon an RS changes nothing but the optics, purely cosmetic. An approved RS during negotiations, especially with low float small caps, shows transactional readiness and if implemented can help streamline the process of closing the deal as well as payouts. Just my speculation until it’s not GLTA NFA
